DN Stock Overview
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Delta 9 Cannabis Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.03 |
| 52 Week High | CA$0.08 |
| 52 Week Low | CA$0.015 |
| Beta | 1.34 |
| 1 Month Change | -40.00% |
| 3 Month Change | 33.33% |
| 1 Year Change | -45.45% |
| 3 Year Change | -94.55% |
| 5 Year Change | -97.97% |
| Change since IPO | -98.96% |
Recent News & Updates
Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story
Mar 26
Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost
Mar 26Recent updates
Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story
Mar 26Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost
Mar 26Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?
Sep 09Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%
Jul 28Does Delta 9 Cannabis (TSE:DN) Have A Healthy Balance Sheet?
Aug 19Is Delta 9 Cannabis (TSE:DN) A Risky Investment?
Jan 11Delta 9 Cannabis (TSE:DN) Is Making Moderate Use Of Debt
Sep 28Delta 9 Cannabis (TSE:DN) Is Carrying A Fair Bit Of Debt
Apr 08John Arbuthnot Is The Co-Founder of Delta 9 Cannabis Inc. (TSE:DN) And They Just Picked Up 1.0% More Shares
Dec 24
Shareholder Returns
| DN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 50.0% | 26.2% | -1.1% |
| 1Y | -45.5% | 84.7% | 4.9% |
Return vs Industry: DN underperformed the Canadian Pharmaceuticals industry which returned 45.6% over the past year.
Return vs Market: DN underperformed the Canadian Market which returned 5.1% over the past year.
Price Volatility
| DN volatility | |
|---|---|
| DN Average Weekly Movement | 44.3% |
| Pharmaceuticals Industry Average Movement | 15.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: DN's share price has been volatile over the past 3 months.
Volatility Over Time: DN's weekly volatility has increased from 28% to 44% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 320 | John Arbuthnot | www.delta9.ca |
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products.
Delta 9 Cannabis Inc. Fundamentals Summary
| DN fundamental statistics | |
|---|---|
| Market cap | CA$8.68m |
| Earnings (TTM) | -CA$17.52m |
| Revenue (TTM) | CA$71.07m |
0.1x
P/S Ratio-0.5x
P/E RatioIs DN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DN income statement (TTM) | |
|---|---|
| Revenue | CA$71.07m |
| Cost of Revenue | CA$56.62m |
| Gross Profit | CA$14.44m |
| Other Expenses | CA$31.96m |
| Earnings | -CA$17.52m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.061 |
| Gross Margin | 20.33% |
| Net Profit Margin | -24.65% |
| Debt/Equity Ratio | -692.6% |
How did DN perform over the long term?
See historical performance and comparison